Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls.

Peter JirakRudin Pistulli Michael Lichtenauer Bernhard WernlyVera PaarLukas J MotlochRichard RezarChristian JungUta C HoppeP Christian SchulzeDaniel KretzschmarRüdiger C Braun-DullaeusTarek Bekfani

Published in: Journal of clinical medicine (2020)

Based on their differences in secretion patterns, novel cardiovascular biomarkers might represent a promising diagnostic tool for HFpEF in the future.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
binding protein
peritoneal dialysis
heart failure